biominas brasil

NOTÍCIAS

Latin America Highlights at BIO International Convention

BIO INTERNATIONAL CONVENTION
Schedule of Brazil and Latin America Programming & Events
 
Prepared for:
BIO International Advocacy Steering Committee, Brazil / L.A. Working Group
Programming and Events listed by country, then by order of day & time. 
 
\"bandeiraBRAZIL
 
World Cup Viewing Party (By Invitation Only)
Date: Monday, June 23rd
Time: 12:00PM – 4:00PM
Location: Hennessey\’s Tavern
Address: 708 4th Ave, San Diego
Thank you to EMD Serono for their support of this event.
 
Biosimilars Regulations: A Perspective from Influential Global Regulators
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/103914  
Date: Tuesday, June 24th
Time: 1:30PM – 3:30PM
Location: Room 4
Translation is available in English/Portuguese/Spanish
Description: Regulatory agency officials from around the world will be moderated by an industry representative to discuss scientific and regulatory issues for biosimilars, including specific requirements for approval of biosimilars, interchangeability and implications for substitution. Discussion of approval requirements will address, among other topics, clinical trials, extrapolation of data and immunogenicity. Naming, labeling, and pharmacovigilance issues will also be addressed. How are global health authorities approaching these issues and what are the main challenges and concerns.
Confirmed
  • Jay Siegel, Chief Biotechnology Officer and Head, Scientific Strategy and Policy, Johnson & Johnson, U.S.A. (Moderator)
  • Lic. Mikel Arriola, Commissioner, COFEPRIS (Mexico)
  • Dirceu Barbano, President, ANVISA; Member, Brazilian National Biotechnology Committee (Brazil)
Invited
  • Ian Hudson, Chief Executive, MHRA (U.K.)
  • Anthony Ridgway, Senior Regulatory Scientist, Office of the Director, Health Canada (Canada)
 
Pursuing Biotechnology Patent Protection in the U.S. and Latin America
Track: Intellectual Property
http://mybio.zerista.com/event/member/103946   
Date: Tuesday, June 24th
Time: 3:00PM – 4:00PM
Location: Room 23ABC
Description: The panelists include the Heads of the Intellectual Property (IP) offices of Mexico and Chile, and the Chief Judge of the U.S. Court of Appeals for the Federal Circuit. These panelists will bring three different perspectives to a discussion of various hot topics in biotechnology patent protection in the U.S. and Latin America. Topics will include: patent filing trends, unique and common challenges in patent examination, scope of subject matter eligible for patent protection, and recent legal and legislative developments impacting biotechnology patent protection in the three countries. This panel discussion will provide an overview of patent protection of biotechnology inventions and current issues facing each country. The panel will be moderated by a former U.S. Patent and Trademark Office official who oversaw the agency’s international policies and activities.
Confirmed
  • Jasemine Chambers, Of Counsel, Wilson Sonsini Goodrich & Rosati, P.C., U.S.A. (Moderator)
  • Miguel Ángel Margáin, Director, Instituto Mexicano de la Propiedad Industrial (Mexico)
  • Randall Rader, Chief Judge, U.S. Court of Appeals for the Federal Circuit (U.S.A.)
  • Maximiliano Santa Cruz, Director, Instituto Nacional de Propiedad Industrial (Chile)
 
Partners in Pharmacovigilance: Empowering Patients in Latin America
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/103915  
Date: Tuesday, June 24th

Time: 3:45PM – 5:00PM

Location: Room 4
Translation is available in English/Portuguese/Spanish
Special thanks to Kira Alvarez of AbbVie for organizing this session.
Description: Pharmacovigilance regimes are an important part of the risk management plans required by the new biologics and biosimilars regulations being implemented throughout the region and play a key role in ensuring patient safety. Panel will provide a perspective on how patient groups and the stakeholders interacting with them view the importance of pharmacovigilance, as well as a candid assessment of the challenges in the region with suggested next steps and calls to action.
Confirmed
  • Dr. Freddy J Faccin L, Associate Medical Director – Biotherapeutics, GMA – GPRD, AbbVie (Moderator)
  • Dr. Inés Bignone, Director of Evaluation of Medicines, ANMAT (Argentina)
  • Gustavo Campinos, Presidente, Fundación Red De Apoyo Social de Antioquia; RASA (Colombia)
  • Dr. Eduardo Mysler, Director, OMI (Argentina)
  • Eva Maria Ruiz de Castilla, Board Member, IAPO (United Kingdom)
  • Dr. Francisco Zaragozá García, Chair, Pharmacology at the University of Alcalá; Member, Scientific Committee for the National Research Promotion Plan, Ministry of Industry (Spain)
 
Brazil Bilateral Breakfast Meeting (By Invitation Only)
Date: Wednesday, June 25th
Time: 8:00AM – 10:00AM
Location: Room 2
Translation is available in English/Portuguese
 
BRAZIL DAY – Programming Listed Below
Forum: Emerging Opportunities in Global Markets
Date: Wednesday, June 25th
Time: 10:15AM – 5:00PM
Location: Room 3
Translation is available in English/Portuguese
10:15AM – 12:00PM
Brazil’s Science Without Borders Program: What is Being Done to Educate Tomorrow’s Leaders?
http://mybio.zerista.com/event/member/123447  
Translation is available in English/Portuguese
Special thanks to Catherine Robinson of Amgen for organizing this session.
Description: In 2011, Brazil introduced the international student exchange program Science Without Borders to promote the consolidation and expansion of science, technology and innovation in Brazil. The government-funded program places Brazilian science, technology, engineering and math (STEM) students at international universities and research institutions. Three years later, this panel will explore the success of the program, how biotechnology companies are contributing and helping to build scientific capacity in Brazil and the needs of the students when they return to Brazil. The panel will feature a student who participated in the program and upon return to Brazil was hired to work for the company’s Brazilian affiliate.
Confirmed
  • Laura Hamill, Vice President LACAN, Amgen (Moderator)
  • Prof. Jorge Almeida Guimarães, President, CAPES (Brazil)
  • Rogerio Ribeiro, SVP & Area Head Emerging Markets and Asia Pacific, GlaxoSmithKline
  • Reginald Seeto, VP Partnering & Strategy, MedImmune (U.S.A.)
Invited
  • Dr. Glaucius Oliva, Presidente, CNPq (Brazil)
 
1:30PM – 2:40PM
How Efficient and Transparent Clinical Trial Regulations Enhance Science, Innovation and Health Outcomes in Emerging Markets
http://mybio.zerista.com/event/member/123446  
Translation is available in English/Portuguese
Special thanks to Catherine Robinson of Amgen for organizing this session.
Description: This panel will focus on the value of clinical trials with a focus on how clinical trials 1) improve health outcomes; 2) attract and retain high quality clinicians and improve the skills and knowledge of clinical staff by implementing the latest clinical improvements; 3) improve clinical standards while promoting academic evidence-based practice; 4) attract research dollars that provide funding for research infrastructure; 5) positively impact health care standards; and 6) most importantly, patients are motivated and receive the benefits of the most advanced treatments. Lastly, the panelists will discuss trends in clinical trial placement and best practices from around the world.
Confirmed
  • Eric Walczykowski, Vice President, Life Sciences, Thompson Reuters, U.S.A. (Moderator)
  • Lic. Mikel Arriola, Commissioner, COFEPRIS (Mexico)
  • Dirceu Barbano, President, ANVISA (Brazil)
  • Cláudia Simone Costa de Cunha, Advisor on Research and Innovation, EBESERH (Brazil)
  • Jorge Otero, Executive Medical Director LACAN, Amgen
 
2:50PM – 3:50PM
World Cup! – Industrial Biotech’s Elite Look to Brazil for Big Wins.
http://mybio.zerista.com/event/member/123448  
Translation is available in English/Portuguese
Description: Soccer fans aren’t the only ones looking to Brazil in 2014. Leading industrial biotech firms from around the world are converging on Brazil – boosting an emerging domestic industrial biotech sector. Perspectives on the industrial biotech boom in Brazil.
Confirmed
  • Vonnie Estes, Managing Director, GranBio (Brazil)
  • Jonathan Wolfson, Chief Executive Officer, Solazyme, Inc (U.S.A.)
 
4:00PM – 5:00PM
Evolution and Trends in Public Policies for Biotechnology in Brazil
http://mybio.zerista.com/event/member/123643 
Translation is available in English/Portuguese
Confirmed
  • Nelson A. Fujimoto, Secretary of Innovation, Ministry of Development, Industry and Foreign Trade (MDIC), Brazil (Moderator)
  • Otávio Brandelli – President, National Institute of Industrial Property (INPI) (Brazil)
  • Pedro Lins Palmeira Filho, Head of Pharmaceutical and Biotech Department, Brazilian Development Bank (BNDES) (Brazil)
  • Maria Sueli Felipe – Innovation Coordinator, Brazilian Agency for Industrial Development (ABDI) (Brazil)
 
Brazil Reception (By Invitation Only)
Location: Stingaree
Address: 454 6th Ave, San Diego, CA 92101
Date: Wednesday, June 25th
Time: 6:00PM – 8:00PM
Thank you to our sponsors AbbVie, Allergan and AstraZeneca Brasil.
 
Building the Bioeconomy: Examining National Biotechnology Industry Development Strategies
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/105412   
Date: Thursday, June 26th
Time: 8:30 AM – 9:30 AM
Location: Room 3
Description: Almost every country today, both developed as well as emerging countries, identify and define the field of biotechnology as a strategic priority to their national interest. Nevertheless, while the appreciation of the importance of biotechnology continues to increase, in recent years developing a sophisticated national biotechnology capacity has become a much riskier, more complex and costly endeavor. Consequently, policymakers and stakeholders have an intensified interest in understanding and identifying the desired set of national policy tools needed to encourage the growth and development of the biotechnology industry from the most basic level of research to full-blown commercialized products.
This panel examines recent research on the topic on national biotechnology strategies and begins to assess their effectiveness in fostering innovation locally.
Confirmed
  • McLean Sibanda, Chief Executive Officer, The Innovation Hub (South Africa)
  • Eduardo Emrich Soares, President, Biominas (Brazil)
 
Spotlight on Emerging Market Vaccine Companies: Enhancing Capabilities for Global Impact
Forum: Vaccines & Immunotherapeutics
http://mybio.zerista.com/event/member/103957   
Date: Thursday, June 26th
Time: 9:00AM – 10:15AM
Location: Room 10
Description: This session will focus on the research and partnership strategies of vaccine developers in three of the leading emerging biotechnology markets,
particularly India, Brazil and China. In recent years, these countries have made advancements in the field, gaining global standing through the development and delivery of affordable vaccines and the establishment of innovative public-private partnerships to serve public health needs of their country as well as developing countries. This session will explore the successes of these emerging manufacturers to date and what innovative developments lay ahead.
Confirmed
  • Peter Khoury, Senior Program Officer, Life Sciences Partnership, Bill & Melinda Gates Foundation, U.S.A. (Moderator)
  • Mahima Datla, Managing Director, Biological E. Limited (India)
  • Suresh Jadhav, Executive Director-Quality Assurance and Regulator, Serum Institute of India Ltd. (India)
  • Dr. Luciana Leite, Director Biotechnology, Instituto Butantan (Brazil)
 
 
 \"bandeiraMEXICO
 
Biosimilars Regulations: A Perspective from Influential Global Regulators
Track: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/103914  
Date: Tuesday, June 24th
Time: 1:30PM – 3:30PM
Location: Room 4
Translation is available in English/Portuguese/Spanish
Description: Regulatory agency officials from around the world will be moderated by an industry representative to discuss scientific and regulatory issues for biosimilars, including specific requirements for approval of biosimilars, interchangeability and implications for substitution. Discussion of approval requirements will address, among other topics, clinical trials, extrapolation of data and immunogenicity. Naming, labeling, and pharmacovigilance issues will also be addressed. How are global health authorities approaching these issues and what are the main challenges and concerns.
Confirmed
  • Jay Siegel, Chief Biotechnology Officer and Head, Scientific Strategy and Policy, Johnson & Johnson, U.S.A. (Moderator)
  • Lic. Mikel Arriola, Commissioner, COFEPRIS (Mexico)
  • Dirceu Barbano, President, ANVISA; Member, Brazilian National Biotechnology Committee (Brazil)
Invited
  • Ian Hudson, Chief Executive, MHRA (U.K.)
  • Anthony Ridgway, Senior Regulatory Scientist, Office of the Director, Health Canada (Canada)
 
Partners in Pharmacovigilance: Empowering Patients in Latin America
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/103915   
Date: Tuesday, June 24th
Time: 3:45PM – 5:00PM
Location: Room 4
Translation is available in English/Portuguese/Spanish
Special thanks to Kira Alvarez of AbbVie for organizing this session.
Description: Pharmacovigilance regimes are an important part of the risk management plans required by the new biologics and biosimilars regulations being implemented throughout the region and play a key role in ensuring patient safety. Panel will provide a perspective on how patient groups and the stakeholders interacting with them view the importance of pharmacovigilance, as well as a candid assessment of the challenges in the region with suggested next steps and calls to action.
Confirmed
  • Dr. Freddy J Faccin L, Associate Medical Director – Biotherapeutics, GMA – GPRD, AbbVie (Moderator)
  • Dr. Inés Bignone, Director of Evaluation of Medicines, ANMAT (Argentina)
  • Gustavo Campinos, Presidente, Fundación Red De Apoyo Social de Antioquia; RASA (Colombia)
  • Dr. Eduardo Mysler, Director, OMI (Argentina)
  • Eva Maria Ruiz de Castilla, Board Member, IAPO (United Kingdom)
  • Dr. Francisco Zaragozá García, Chair, Pharmacology at the University of Alcalá; Member, Scientific Committee for the National Research Promotion Plan, Ministry of Industry (Spain)
 
Pursuing Biotechnology Patent Protection in the U.S. and Latin America
Track: Intellectual Property
http://mybio.zerista.com/event/member/103946   
Date: Tuesday, June 24th
Time: 3:00PM – 4:00PM
Location: Room 23ABC
Description: The panelists include the Heads of the Intellectual Property (IP) offices of Mexico and Chile, and the Chief Judge of the U.S. Court of Appeals for the Federal Circuit. These panelists will bring three different perspectives to a discussion of various hot topics in biotechnology patent protection in the U.S. and Latin America. Topics will include: patent filing trends, unique and common challenges in patent examination, scope of subject matter eligible for patent protection, and recent legal and legislative developments impacting biotechnology patent protection in the three countries. This panel discussion will provide an overview of patent protection of biotechnology inventions and current issues facing each country. The panel will be moderated by a former U.S. Patent and Trademark Office official who oversaw the agency’s international policies and activities.
Confirmed
  • Jasemine Chambers, Of Counsel, Wilson Sonsini Goodrich & Rosati, P.C., U.S.A. (Moderator)
  • Miguel Ángel Margáin, Director, Instituto Mexicano de la Propiedad Industrial (Mexico)
  • Randall Rader, Chief Judge, U.S. Court of Appeals for the Federal Circuit (U.S.A.)
  • Maximiliano Santa Cruz, Director, Instituto Nacional de Propiedad Industrial (Chile)
 
The Power of TPP: A Vehicle for Promoting Cross-Pacific Collaboration and Innovation
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/105169  
Date: Wednesday, June 25th

Time: 4:30PM – 5:45PM

Location: Room 5A
Description: The TPP negotiations, now in their fourth year, bring together the United States, Japan, and 10 other Asia Pacific economies to lower barriers to commerce, improve intellectual property rights, and expand cross-border collaboration. This session will review the negotiations and its broad-ranging implications. In particular the panel will discuss aspects of the agreement which are mission critical for the biotech industry, including changes to Intellectual Property regimes, regulatory harmonization (or the opposite) and market access issues, particularly for new and innovative therapies. Invariably this will traverse hot topics such as biosimilars, gene patenting, data protection, ever-greening and government policies which denude patents of a substantial portion of their value.
Accepted
  • Brian Pomper, Partner, Akin Gump Strauss Hauer & Feld LLP, U.S.A. (Moderator)
  • Juan Antonio Dorantes, Director General of International Trade Rules, Ministry of Economy (Mexico)
  • Mark Elliot, Executive Vice President, U.S. Chamber of Commerce, Global IP Center (U.S.A.)
  • Declan Hamill, Chief of Staff & Vice President, Legal Affairs, R&D, Canada’s Research-Based Pharmaceutical Company (Canada)
  • Paul Neureiter, Executive Director, Amgen (U.S.A.)
Invited
  • Probir Mehta, Acting Assistant USTR for Intellectual Property (U.S.A.)
 
Mexico Bilateral Breakfast Meeting (By Invitation Only)
Date: Thursday, June 26th
Time: 8:00AM – 9:00AM
Location: Room 2
Translation is available in English/Spanish
 
Inter-Institutional Agreement of Cooperation Between Health Agencies of the Pacific Alliance: Future Expectations for Biologics Regulations
http://mybio.zerista.com/event/member/103966  
Forum: Emerging Opportunities in Global Markets
Date: Thursday, June 26th
Time: 9:15AM – 10:45AM
Room 5A
Translation is available in English/Spanish
Special thanks to Baker & McKenzie for their support of this panel.
Description: The signing of the Inter-Institutional Agreement of Cooperation between health agencies of the Pacific Alliance took place with the participation of the Mexican Undersecretary for Foreign Trade at the Ministry of the Economy, Francisco de Rosenzweig and COFEPRIS Commissioner Mikel Arriola, along with their counterparts from Chile, Colombia and Peru. Certain biologics regulatory issues are important for these countries and impact the region. These important issues will be examined in the session.
Confirmed
  • Dr. Christian Lopez-Silva, Partner (Local), Head of Pharmaceuticals & Life Sciences, Baker & McKenzie, S.C., Mexico (Moderator)
Invited
  • Señora Midori de Habich Rospigliosi, Ministra de Estado en el Despacho de Salud, Ministerio de Salud (Peru)
  • Dr. Alejandro Gaviria Uribe, Ministro, Ministerio de Salud y Protección Social (Colombia)
  • Fabiola Munoz Espinoza, Jefa de Subdepartamento de Registros, ANAMED Agencia Nacional de Medicamentos (ANAMED)and Instituto de Salud Publica (ISP)(Chile)
 
Viva La Collaboration! How Mexican Policy is Leveraging Public-Private Partnerships to Spur Innovation and Investment
Track: International Market Briefing/organized by Fernando Quezada
http://mybio.zerista.com/event/member/104227  
Date: Thursday, June 26th
Time: 11:00AM – 11:45AM
Location: Room 5B
Description: Since the inauguration of Mexico’s current President Enrique Peña Nieto at the end of 2012, there has been renewed interest in diversifying the nature and scope of public-private R&D partnerships. The current government plans to increase the federal budget for R&D to at least one percent of GDP. New biotechnology initiatives are underway at the federal and at the state level to stimulate innovation in medicine, agriculture, environmental protection and related areas. This session will highlight the various policy instruments Mexico is pursuing to enable public-private partnerships in biotechnology development and innovation across these sectors. Session speakers will discuss recent success stories and highlight opportunities for international participation.
Confirmed
  • Fernando Quezada, Executive Director, Biotechnology Center of Excellence Corporation, U.S.A. (Moderator)
  • Jesus Paniagua, Senior Researcher, Ctr. Scientific Research Ensenada (Mexico)
  • Roberto Trujillo, President and CEO, TruBios (U.S.A.)
  • Mary Walshok, Associate Vice Chancellor for Public Programs, UCLA (U.S.A.)
 
 
 \"bandeiraCHILE
 
Pursuing Biotechnology Patent Protection in the U.S. and Latin America
Track: Intellectual Property
http://mybio.zerista.com/event/member/103946  
Date: Tuesday, June 24th
Time: 3:00PM – 4:00PM
Location: Room 23ABC
Description: The panelists include the Heads of the Intellectual Property (IP) offices of Mexico and Chile, and the Chief Judge of the U.S. Court of Appeals for the Federal Circuit. These panelists will bring three different perspectives to a discussion of various hot topics in biotechnology patent protection in the U.S. and Latin America. Topics will include: patent filing trends, unique and common challenges in patent examination, scope of subject matter eligible for patent protection, and recent legal and legislative developments impacting biotechnology patent protection in the three countries. This panel discussion will provide an overview of patent protection of biotechnology inventions and current issues facing each country. The panel will be moderated by a former U.S. Patent and Trademark Office official who oversaw the agency’s international policies and activities.
Confirmed
  • Jasemine Chambers, Of Counsel, Wilson Sonsini Goodrich & Rosati, P.C., U.S.A. (Moderator)
  • Miguel Ángel Margáin, Director, Instituto Mexicano de la Propiedad Industrial (Mexico)
  • Randall Rader, Chief Judge, U.S. Court of Appeals for the Federal Circuit (U.S.A.)
  • Maximiliano Santa Cruz, Director, Instituto Nacional de Propiedad Industrial (Chile)
 
Building a New Bio Industry, a Private-Public Initiative: The Case of Chile
Track: International Market Briefings
http://mybio.zerista.com/event/member/104585  
Date: Thursday, June 26th
Time: 2:15PM – 3:00PM
Location: Room 5B
Description: This panel will identify and evaluate the set of conditions necessary to promote and foster the development of a new innovative industry in a developing country. Through a partnership of the main stakeholders from private, public and academia, and utilizing a holistic approach to assess the complete value-chain of the bio-renewable industry in Chile, the group has elaborated an integrated proposal of actions the country would have to undergo to increase the probability of successfully creating this new industry.
Key Takeaways:
  • Insights related to designing public policies through private-public partnership in a developing country
  • Main challenges and value drivers for a second generation bio-renewable industry and the justification for government involvement
  • Key initiatives that are requires for the creation of a bio renewable industry and how it affects the different actors of the value chain
Confirmed
  • Gabriela Gerbin Cezar, Head External R&D Innovation South America, Pfizer (Brazil)
  • Sebastián Flores, Project Director, Chile Bio Renovables (Chile)
  • Jose Nunez, Environmental Senior Manager, LATAM Airlines Group (Chile)
  • Katia Trusich, Undersecretary of Economy, Ministry of the Economy, Government of Chile
 
 
\"bandeira COLOMBIA
 
Inter-Institutional Agreement of Cooperation Between Health Agencies of the Pacific Alliance: Future Expectations for Biologics Regulations
http://mybio.zerista.com/event/member/103966  
Forum: Emerging Opportunities in Global Markets
Date: Thursday, June 26th
Time: 9:15AM – 10:45AM
Room 5A
Translation is available in English/Spanish
Special thanks to Baker & McKenzie for their support of this panel.
Description: The signing of the Inter-Institutional Agreement of Cooperation between health agencies of the Pacific Alliance took place with the participation of the Mexican Undersecretary for Foreign Trade at the Ministry of the Economy, Francisco de Rosenzweig and COFEPRIS Commissioner Mikel Arriola, along with their counterparts from Chile, Colombia and Peru. Certain biologics regulatory issues are important for these countries and impact the region. These important issues will be examined in the session.
Confirmed
  • Dr. Christian Lopez-Silva, Partner (Local), Head of Pharmaceuticals & Life Sciences, Baker & McKenzie, S.C., Mexico (Moderator)
Invited
  • Señora Midori de Habich Rospigliosi, Ministra de Estado en el Despacho de Salud, Ministerio de Salud (Peru)
  • Dr. Alejandro Gaviria Uribe, Ministro, Ministerio de Salud y Protección Social (Colombia)
  • Fabiola Munoz Espinoza, Jefa de Subdepartamento de Registros, ANAMED Agencia Nacional de Medicamentos (ANAMED)and Instituto de Salud Publica (ISP)(Chile)
 
 
\"seta\"REGIONAL INTEREST, NOT LISTED ELSEWHERE
 
Opening Plenary
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/104558  
Date: Tuesday, June 24th
Time: 10:30AM – 12:00PM
Location: Room 4
Description: This session will provide an overview of global issues confronting the biotech sector by bringing together prominent policy and business officials, and setting the stage for the next three days of panel sessions.
Confirmed
  • David Brancaccio, Host, American Public Media’s Marketplace Morning Report, U.S.A. (Moderator)
 
Get Your WorldView On: A Special Scientific American Presentation
Forum: Emerging Opportunities in Global Markets
http://mybio.zerista.com/event/member/110466  
Date: Thursday, June 26th
Time: 12:45 PM–1:45 PM
Location: Room 5A
Description: Scientific American WorldView, now in its sixth year, is the definitive hub of international biotechnology progress. The unique WorldView \”Scorecard\”, a country-by-country outlook of the best innovation climates for life science knowledge development has become a key industry index and is watched by policymakers, scientists and global financial opinion leaders alike. Come hear the editors reveal the winners and tell some fascinating stories behind the data, including a look back at how different regions have changed positions over the years.
Confirmed
  • Yali Friedman, PhD, Chief Editor, Journal of Commercial Biotechnology, thinkBiotech (U.S.A.)
  • Mike May, Editorial Director, Scientific American (U.S.A.)
 
Scientific American WorldView Super Session – Biotech: We are the World
Track: Super Sessions
http://mybio.zerista.com/event/member/103976  
Date: Thursday, June 26
Time: 2:00PM – 3:30PM
Location: Room 6AB
Description: What is happening in biotechnology and life science development on the global stage? What are the most pressing issues of our time that have every nation looking to science as a solution?
As the world continues to flatten, individual countries are finding new ways to grow their innovation engines, and in some cases, are hoping to outshine the US.
Come to the annual Scientific American WorldView super session to hear a dynamic panel of international industry luminaries examine the future of global innovation in a lively candid conversation.
Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, this event will explore key themes from Scientific American’s annual biotechnology edition, featuring the WorldView Scorecard and fresh perspectives on international life science development.
Confirmed
  • David Brancaccio, Host, American Public Media’s Marketplace Morning Report, U.S.A. (Moderator)
  • Francis Gurry, Director General, World Intellectual Property Organization (WIPO) (Switzerland)
 
Private Meeting with the Association of University Technology Managers (AUTM)
Representatives from AUTM will be available for private meetings throughout the Convention. The core purpose of AUTM is to support and advance academic technology transfer globally. In this meeting, delegates will gain a better understanding of the importance of technology transfer promoting legislation and policies and AUTM’s professional development services.
If you are interested in setting up a meeting please send an email with desired date, time, requesting organization and number of meeting delegates to Sarah Orye at sorye@conventusllc.com.
For more information on AUTM please visit their website at http://www.autm.net/Home.htm
 
Optional Site Visits to Local Biotech Companies
If your government has an interest in visiting any of the below facilities, please send an email including facility name, date, requesting organization and number of delegates to Sarah Orye at sorye@conventuslls.com
 
Academic/Research/Incubator in the San Diego Area
 
Sanford Consortium for Regenerative Medicine
http://www.sanfordconsortium.org/
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
 
The Scripps Research Institute
www.scripps.edu
3301 North Torrey Pines Court, La Jolla, CA
 
Salk Institute for Biological Studies
www.salk.edu
10010 N. Torrey Pines Rd., La Jolla, CA 92037
 
La Jolla Institute for Allergy and Immunology
http://www.liai.org/
9420 Athena Cir, La Jolla, CA 92037
 
University of California – San Diego
http://ctri.ucsd.edu/Pages/default.aspx
9444 Medical Center Dr. La Jolla, CA 92093
 
Moores Cancer Center
http://cancer.ucsd.edu/Pages/default.aspx
3855 Health Sciences Dr, La Jolla, CA 92093
 
The Neurosciences Institute
www.nsi.edu/homepage.html
800 Silverado Street, Suite 302, La Jolla, California 92037-4234
 
Janssen Labs
www.janssenlabs.com
3210 Merryfield Row, San Diego, CA 92121
 
Companies in the San Diego Area
 
Eli Lilly
http://www.lilly.com/Pages/Home.aspx
10300 Campus Point Drive Suite 200. San Diego California 92121
 
Pfizer
www.pfizer.com/research/science_and_technology/rd_locations/ca_la_jolla
10646 Science Center Dr, San Diego, CA 92121
 
Takeda California
http://takedacalifornia.com/
10410 Science Center Drive, San Diego, CA 92121
 
Ardea Biosciences (AZ subsidiary)
http://www.ardeabio.com/
4939 Directors Place, San Diego, CA 92121
 
Arena Pharmaceuticals
http://www.arenapharm.com/
6154 Nancy Ridge Drive, San Diego, CA 92121
 
Rempex Pharmaceuticals (recently bought by The Medicines Company)
http://www.rempexpharma.com/
11535 Sorrento Valley Road, San Diego, CA 92121
 
Vertex Pharmaceuticals
https://www.vrtx.com/
11010 Torreyana Rd, San Diego, CA 92121
 
COI Pharmaceuticals
http://www.coipharma.com/
11099 North Torrey Pines Road, Suite 290, La Jolla, CA 92037
 
Companies and Academia in Los Angeles and Surrounding Area
 
Gilead
http://www.gilead.com/
650 Cliffside Drive, San Dimas, CA 91773
 
Allergan (headquarters)
http://www.allergan.com/index.htm
18581 Teller Ave #150, Irvine, CA 92612
 
Amgen (headquarters)
www.amgen.com
One Amgen Center Drive, Thousand Oaks, CA 91320
 
Baxter
http://www.baxter.com/index.html
700 Rancho Conejo Boulevard, Thousand Oaks, CA 91320
 
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
http://labiomed.org/
1124 West Carson St. Torrance, CA 90502
 
Companies and Research in San Francisco and Surrounding Area
 
BioMarin
http://www.bmrn.com/about-us/index.php
105 Digital Drive, Novato, CA 94949
 
Novartis
http://www.novartis.com/index.shtml
1125 Green St, San Francisco, CA 94109
 
California Institute for Regenerative Medicine
(aka California\’s Stem Cell Agency)
http://www.cirm.ca.gov/
210 King Street, San Francisco, CA 94107
 
\"banner

Posts Relacionados

Faça uma busca
Categorias
Instagram Linkedin Facebook

Todos os direitos reservados © –Biominas Brasil– 2024
Desenvolvido por FAC DIGITAL

  • Contato
  • Endereço: Av. José Cândido da Silveira, 2100 - Horto, Belo Horizonte - MG, 31035 - 536
  • Telefone: +55 (31) 3303-0000
  • E-mail: biominas@biominas.org.br
Rolar para cima